Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“The Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK) recently celebrated 20 years of discovery, leadership, and impact in translational oncology. HOPP supports innovation and collaboration between talented physicians and scientists who are at the leading edge of bench- to-bedside research.
HOPP’s research programs span multiple cancer types, and its scientists employ innovative technologies, often redefining how we find, develop, and test new cancer therapies. The program also supports graduate and postdoctoral training for physicians and scientists who want to serve at the cutting-edge of translational cancer research.
Swipe through images from the celebratory event and learn more about the program.”
Other articles featuring Memorial Sloan Kettering Cancer Center on OncoDaily.
